|
1
|
Ahmed SN: Epileptic seizures and epilepsy.
Epilepsia. 46:1700–1702. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ding D, Hong Z, Wang WZ, Wu JZ, de Boer
HM, Prilipko L and Sander JW: Assessing the disease burden due to
epilepsy by disability adjusted life year in rural China.
Epilepsia. 47:2032–2037. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zaccara G and Perucca E: Interactions
between antiepilepticdrugs, and between antiepileptic drugs and
other drugs. Epileptic Disord. 16:409–431. 2014.PubMed/NCBI
|
|
4
|
Greenwood RS: Adverse effects of
antiepileptic drugs. Epilepsia. 41 Suppl 2:S42–S52. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang XQ, Lang SY, Shi XB, Tian HJ, Wang RF
and Yang F: Antiepileptic drug-induced skin reactions: A
retrospective study and analysis in 3793 Chinese patients with
epilepsy. Clin Neurol Neurosurg. 114:862–865. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang XQ, Shi XB, Au R, Chen FS, Wang F and
Lang SY: Influence of chemical structure on skin reactions induced
by antiepileptic drugs - the role of the aromatic ring. Epilepsy
Res. 94:213–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lonjou C, Thomas L, Borot N, Ledger N, de
Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt
M, et al RegiSCAR Group, : A marker for Stevens-Johnson syndrome
& Ethnicity matters. Pharmacogenomics J. 6:265–268. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lujić L, Bošnjak VM, Duranović V, Daković
I, Kapović AM, Barčot Z and Jureković II: Idiosyncratic adverse
reactions to aromatic antiepileptic drugs. Paediatr Croat.
57:165–170. 2013.
|
|
9
|
Hung SI, Chung WH, Liu ZS, Chen CH, Hsih
MS, Hui RC, Chu CY and Chen YT: Common risk allele in aromatic
antiepileptic-drug induced Stevens-Johnson syndrome and toxic
epidermal necrolysis in Han Chinese. Pharmacogenomics. 11:349–356.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheung YK, Cheng SH, Chan EJ, Lo SV, Ng MH
and Kwan P: HLA-B alleles associated with severe cutaneous
reactions to antiepileptic drugs in Han Chinese. Epilepsia.
54:1307–1314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tassaneeyakul W, Tiamkao S,
Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P,
Khunarkornsiri U, Auvichayapat N, Pavakul K, et al: Association
between HLA-B'1502 and carbamazepine-induced severe cutaneous
adverse drug reactions in a Thai population. Epilepsia. 51:926–930.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mehta TY, Prajapati LM, Mittal B, Joshi
CG, Sheth JJ, Patel DB, Dave DM and Goyal RK: Association of
HLA-B'1502 allele and carbamazepine-induced Stevens-Johnson
syndrome among Indians. Indian J Dermatol Venereol Leprol.
75:579–582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hung SI, Chung WH, Jee SH, Chen WC, Chang
YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, et al: Genetic
susceptibility to carbamazepine-induced cutaneous adverse drug
reactions. Pharmacogenet Genomics. 16:297–306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gogtay NJ, Bavdekar SB and Kshirsagar NA:
Anticonvulsant hypersensitivity syndrome: A review. Expert Opin
Drug Saf. 4:571–581. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arif H, Buchsbaum R, Weintraub D, Koyfman
S, Salas-Humara C, Bazil CW, Resor SR Jr and Hirsch LJ: Comparison
and predictors of rash associated with 15 antiepileptic drugs.
Neurology. 68:1701–1709. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abood GJ, Nickoloff BJ and Gamelli RL:
Treatment strategies in toxic epidermal necrolysis syndrome: Where
are we at? J Burn Care Res. 29:269–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lammintausta K and Kortekangas-Savolainen
O: The usefulness of skin tests to prove drug hypersensitivity. Br
J Dermatol. 152:968–974. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Messenheimer JA and Guberman AH: Rash with
lamotrigine: Dosing guidelines. Epilepsia. 41:4882000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chung WH, Hung SI and Chen YT: Genetic
predisposition of life-threatening antiepileptic-induced skin
reactions. Expert Opin Drug Saf. 9:15–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chung WH and Hung SI: Recent advances in
the genetics and immunology of Stevens-Johnson syndrome and toxic
epidermal necrosis. J Dermatol Sci. 66:190–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chung WH, Hung SI, Hong HS, Hsih MS, Yang
LC, Ho HC, Wu JY and Chen YT: Medical genetics: A marker for
Stevens-Johnson syndrome. Nature. 428:4862004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng CY, Su SC, Chen CH, Chen WL, Deng ST
and Chung WH: HLA associations and clinical implications in T-cell
mediated drug hypersensitivity reactions: An updated review. J
Immunol Res. 2014:5653202014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nguyen DV, Chu HC, Nguyen DV, Phan MH,
Craig T, Baumgart K and van Nunen S: HLA-B'1502 and
carbamazepine-induced severe cutaneous adverse drug reactions in
Vietnamese. Asia Pac Allergy. 5:68–77. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tangamornsuksan W, Chaiyakunapruk N,
Somkrua R, Lohitnavy M and Tassaneeyakul W: Relationship between
the HLA-B'1502 allele and carbamazepine-induced Stevens-Johnson
syndrome and toxic epidermal necrolysis: A systematic review and
meta-analysis. JAMA Dermatol. 149:1025–1032. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amstutz U, Shear NH, Rieder MJ, Hwang S,
Fung V, Nakamura H, Connolly MB, Ito S and Carleton BC; CPNDS
clinical recommendation group, : Recommendations for HLA-B'15:02
and HLA-A'31:01 genetic testing to reduce the risk of
carbamazepine-induced hypersensitivity reactions. Epilepsia.
55:496–506. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsiao YH, Hui RC, Wu T, Chang WC, Hsih MS,
Yang CH, Ho HC, Chang YG, Chen MJ, Lin JY, et al:
Genotype-phenotype association between HLA and
carbamazepine-induced hypersensitivity reactions: Strength and
clinical correlations. J Dermatol Sci. 73:101–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ozeki T, Mushiroda T, Yowang A, Takahashi
A, Kubo M, Shirakata Y, Ikezawa Z, Iijima M, Shiohara T, Hashimoto
K, et al: Genome-wide association study identifies HLA-A'3101
allele as a genetic risk factor for carbamazepine-induced cutaneous
adverse drug reactions in Japanese population. Hum Mol Genet.
20:1034–1041. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leckband SG, Kelsoe JR, Dunnenberger HM,
George AL Jr, Tran E, Berger R, Müller DJ, Whirl-Carrillo M, Caudle
KE and Pirmohamed M; Clinical Pharmacogenetics Implementation
Consortium, : Clinical Pharmacogenetics Implementation Consortium
guidelines for HLA-B genotype and carbamazepine dosing. Clin
Pharmacol Ther. 94:324–328. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kurose K, Sugiyama E and Saito Y:
Population differences in major functional polymorphisms of
pharmacokinetics/pharmacodynamics-related genes in Eastern Asians
and Europeans: Implications in the clinical trials for novel drug
development. Drug Metab Pharmacokinet. 27:9–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McCormack M, Alfirevic A, Bourgeois S,
Farrell JJ, Kasperavičiūtė D, Carrington M, Sills GJ, Marson T, Jia
X, de Bakker PI, et al: HLA-A'3101 and carbamazepine-induced
hypersensitivity reactions in Europeans. N Engl J Med.
364:1134–1143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Genin E, Chen DP, Hung SI, Sekula P,
Schumacher M, Chang PY, Tsai SH, Wu TL, Bellón T, Tamouza R, et al:
HLA-A'31:01 and different types of carbamazepine-induced severe
cutaneous adverse reactions: an international study and
meta-analysis. Pharmacogenomics J. 14:281–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yip VL, Marson AG, Jorgensen AL,
Pirmohamed M and Alfirevic A: HLA genotype and
carbamazepine-induced cutaneous adverse drug reactions: A
systematic review. Clin Pharmacol Ther. 92:757–765. 2012.
View Article : Google Scholar : PubMed/NCBI
|
